Peroxisome Proliferator Activated Receptors and Cannabinoids

E. Muñoz, F. Pollastro, O. Taglialatela-Scafati, G. Appendino

Risultato della ricerca: Capitolo in libro/report/atti di convegnoContributo in volume (Capitolo o Saggio)peer review

Abstract

Cannabinoids are a complex group of molecules that comprise phytocannabinoids, endocannabinoids, and synthetic cannabinoids. Cannabinoids were initially identified by their ability to bind and activate the classical cannabinoid receptors CB1 and CB2. However, cannabinoids are pleiotropic in nature, and also activate other type of receptors, such as transient receptor potential cation channels, ligand-gated ion channels, deorphanized G protein coupled receptors, and peroxisome proliferator activated receptors such as PPAR?. Thus, cannabinoids may exert their biological activities through CB1/CB2-dependent and independent mechanisms, or a combination of both, which is especially relevant in the case of botanical drugs containing mixtures of phytocannabinoids. PPAR? exerts a wide variety of physiological functions, and its pharmacological manipulation has been exploited for the treatment of diabetes. In addition, PPAR? is recognized as a major target for the development of novel therapies aimed at managing chronic inflammatory and neurodegenerative diseases. Here, we review the published literature on cannabinoids and PPAR?, and discuss their potential therapeutic implications.

Lingua originaleInglese
Titolo della pubblicazione ospiteHandbook of Cannabis and Related Pathologies
Sottotitolo della pubblicazione ospiteBiology, Pharmacology, Diagnosis, and Treatment
EditoreElsevier Inc.
Pagine671-679
Numero di pagine9
ISBN (elettronico)9780128008270
ISBN (stampa)9780128007563
DOI
Stato di pubblicazionePubblicato - 24 gen 2017

Fingerprint

Entra nei temi di ricerca di 'Peroxisome Proliferator Activated Receptors and Cannabinoids'. Insieme formano una fingerprint unica.

Cita questo